Dermatology Trials in Elgin

Clinical Research

Dot Grid

Continually advancing dermatology healthcare.

As health professionals, we understand the impact skin has as your body’s largest organ. There is an emotional component to clear, healthy skin, and we’re a part of that journey right alongside you. Our doctors and staff are proud of the work we do in dermatology trials and the results we deliver.

Why Dundee?

Learn More spinning text

What We Do

Our Expertise

Leading pharmaceutical companies have recognized our expertise for participation in FDA-approved dermatology trials in Elgin. We take pride in participating in clinical trials that provide research to treatments and medications that are not yet available.

Dundee Dermatology is recognized for expertise in several common but troublesome dermatologic conditions and serves as a clinical research resource for these conditions.

We have conducted a broad range of studies in phases II through IV of study development and continue active participation in dermatology research efforts for a range of skin conditions.

Paul Getz, MD

Meet the Researcher

Dr. Paul Getz has spent over 30 years as a board-certified dermatologist. He leads our clinical research contributions on treatments, medications, medical devices, and other innovations, particularly in psoriasis and eczema.

Meet Dr. Getz

Current Trials

Now Recruiting for Current Trials.

Become a Participant

Get cutting-edge treatment or medicines.

If you’re a candidate and are interested in receiving the latest advancements in medication or treatment, consider becoming a clinical trial participant. Review our current trial offerings and submit your information to be considered.


"*" indicates required fields

Max. file size: 50 MB.
Max. file size: 50 MB.
This field is for validation purposes and should be left unchanged.

Previous Sponsored Clinical Research Studies

12/2021 – present

Phase III

Eli Lilly and Company

Atopic Dermatitis

10/2021 – present

Phase III



05/2021 – present

Phase III


Atopic Dermatitis

09/2020 – present

Phase III


Hidradenitis Suppurativa

02/2020 – present

Phase III

Bristol Myers Squibb


09/2020 - Preseent

Phase III


Hidradenitis Suppurativa

Dot Grid Dot Grid

Questions about our clinical research?

Contact us to learn more about becoming a participant or partnering with us.